Previous Article | Next Article ![]()
Mol Cell Biol, April 1998, p. 2067-2076, Vol. 18, No. 4
Section on Molecular Structure and Function,
National Eye Institute, National Institutes of Health, Bethesda,
Maryland 208921;
Brigham and Women's
Hospital, Boston, Massachusetts 021152;
and
W. K. Kellogg Eye Center, University of Michigan,
Ann Arbor, Michigan 481053
Received 7 August 1997/Returned for modification 26 September
1997/Accepted 23 December 1997
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Lens-Specific Gene Recruitment of
-Crystallin
through Pax6, Nrl-Maf, and Brain Suppressor Sites


-Crystallin is a taxon-specific crystallin, an enzyme which has
undergone direct gene recruitment as a structural component of the
guinea pig lens through a Pax6-dependent mechanism. Tissue specificity
arises through a combination of effects involving three sites in the
lens promoter. The Pax6 site (ZPE) itself shows specificity for an
isoform of Pax6 preferentially expressed in lens cells. High-level
expression of the promoter requires a second site, identical to an
CE2 site or half Maf response element (MARE), adjacent to the
Pax6 site. A promoter fragment containing Pax6 and MARE sites gives
lens-preferred induction of a heterologous promoter. Complexes binding
the MARE in lens nuclear extracts are antigenically related to Nrl, and
cotransfection with Nrl elevates
-crystallin promoter activity in
lens cells. A truncated
promoter containing Nrl-MARE and Pax6 sites
has a high level of expression in lens cells in transgenic mice but is
also active in the brain. Suppression of the promoter in the brain
requires sequences between
498 and
385, and a site in this region
forms specific complexes in brain extract. A three-level model for
lens-specific Pax6-dependent expression and gene recruitment is
suggested: (i) binding of a specific isoform of Pax6; (ii) augmentation
of expression through binding of Nrl or a related factor; and (iii)
suppression of promoter activity in the central nervous system by an
upstream negative element in the brain but not in the lens.
*
Corresponding author. Mailing address: Section on
Molecular Structure and Function, National Eye Institute, Building 6 Room 331, National Institutes of Health, Bethesda, MD 20892-2740. Phone: (301) 402-3452. Fax: (301) 496-0078. E-mail:
graeme{at}mge2.nei.nih.gov.
Present address: Columbia University, New York, NY 10027.
Present address: Glaxo R&D, Stevenage SG1 2NY, United Kingdom.
§
Present address: Bayer Corp., Clayton, NC 27502.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»